Press release from Companies: DanCann Pharma A/S brings forward the release of the quarterly report for Q3 2022

Press release from Companies: Board of Directors in DanCann Pharma A/S has resolved on a partially (77 percent) secured Rights Issue of approximately DKK 28.5 million and publishes prospectus

Press release from Companies: Board of Directors in DanCann Pharma A/S has resolved on a partially (77 percent) secured Rights Issue of approximately DKK 28.5 million and publishes prospectus

Press release from Companies: DanCann Pharma A/S: Upcoming legalization in the US and Germany will have a major impact on the acceptance of cannabis worldwide

Press release from Companies: DanCann Pharma A/S: Upcoming legalization in the US and Germany will have a major impact on the acceptance of cannabis worldwide

Press release from Companies: DanCann Pharma A/S has appointed Alexander Schoeneck and Jeppe Krog Rasmussen to the Board of Directors

Press release from Companies: DanCann Pharma A/S has appointed Alexander Schoeneck and Jeppe Krog Rasmussen to the Board of Directors

Press release from Companies: DanCann Pharma A/S: Minutes of annual general meeting

Press release from Companies: DanCann Pharma A/S: Minutes of annual general meeting

Press release from Companies: DanCann Pharma A/S: Pain specialist Tina Horsted and DanCann Pharma A/S in collaboration on ambitious patient project

Press release from Companies: DanCann Pharma A/S: Pain specialist Tina Horsted and DanCann Pharma A/S in collaboration on ambitious patient project

Press release from Companies: DanCann Pharma A/S: Carsten Trads, Chairman, comments on the Rights Issue